Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
Morning Overview on MSN
New catheter aims to improve arrhythmia treatment as clinical trials begin
For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results